(Credit-Canva)
We are always told to never mix work and friendships in social settings. While it is normal to make friendships at work, you should always keep a professional distance to make sure things do not go sour and start affecting your work. This also means that you do not divulge private information or have private conversations with your colleagues as you may never know how this could be brought up and affect you. This is an unsaid rule in corporate culture that if you are sick or you are coming down with a serious issue, you should never bring it up and keep it to yourself. While this may seem unusual to new workers, it is a very common knowledge for people who have been in the industry for a long time. A new study showed that this is much more common than many people believe!
A new poll shows that a lot of U.S. workers with long-term health problems keep it a secret from their bosses. This affects their health and their jobs. It's a big problem that employers could help fix, which would be good for everyone. This isn't just about people having a sniffle. We're talking about serious conditions like heart disease, diabetes, and asthma that require ongoing management and can significantly impact a person's life, both inside and outside of work. The fact that so many people feel they need to hide these conditions shows a larger issue of stigma and lack of support in the workplace.
Most U.S. workers which were over half of the people, have some kind of long-term health problem. But a lot of them, about 6 out of 10, don't tell their boss. They might be afraid their boss will treat them differently or think they can't do their job. Keeping secrets like this can make it hard to get the help you need at work. It can also make your health problems worse because you're stressed about hiding them. It's a tough situation, and it shows that many workplaces aren't as supportive as they could be.
The poll also found that more than a third of people with health problems have had to miss doctor's appointments because of work. This means they're putting their jobs ahead of their health, which isn't good. It's hard to balance work and health, especially when you have a long-term illness. People need understanding bosses who will let them take time off for important medical stuff. Missing appointments can make health problems worse, and it can also make people feel more stressed and anxious.
Almost half of the workers with health problems said they couldn't even take breaks during the day to take care of themselves. They also said they felt like they'd been passed over for promotions because of their health. And some people even got bad reviews at work because of their health problems. This can make people feel really bad about themselves and their jobs. It can also make their health problems worse because they're so stressed. It's not fair, and it's something that needs to change.
It's not just people with health problems who have a hard time. Lots of people are also taking care of someone at home who is sick. Almost half of these caregivers have to help their sick family member during work hours. And many of them have trouble taking time off to care for their loved ones. Some people even have to work fewer hours, which means less money. This shows how much pressure people are under, trying to juggle work and family and health.
Credits: Canva
Kidney disease is rising at an alarming pace worldwide, and it’s now among the top causes of death. A Lancet study highlights that the number of people living with chronic kidney disease jumped from 78 million in 1990 to nearly 788 million in 2023. That’s a massive tenfold spike, and a reminder that our kidneys need more attention than we realize.
The tricky part? Kidney problems often progress silently. Many people don’t realize anything is wrong until the kidneys are already significantly damaged. That’s why experts strongly emphasize early screening. According to nephrologists like Dr Arjun Sabharwal, a few simple tests — often quick and inexpensive — can help catch kidney issues early and improve treatment outcomes.
Below are the four key tests everyone should know about, especially if you have diabetes, high blood pressure, a family history of kidney disease, or you’re simply trying to stay proactive about your health.
eGFR uses creatinine values along with age and other factors to estimate how well your kidneys are functioning overall. Doctors often say, “Creatinine is just a number — eGFR tells you how much your kidneys are working.”
An eGFR below normal may be an early signal that your kidneys aren’t filtering efficiently, even if you feel fine.
Cystatin C is a protein produced naturally by all cells. When kidneys are healthy, its levels stay stable; when the kidneys struggle, the levels rise.
Experts highlight that Cystatin C can be more reliable than creatinine for people with very high muscle mass, those who work out intensely, or individuals taking supplements that may affect creatinine readings. If creatinine results seem unclear or inconsistent, this test adds clarity.
Before kidney function takes a major hit, the body often shows early warnings — one of which is protein leakage in urine. A urine dipstick test is one of the fastest ways to detect this.
A chemically treated strip is dipped into your urine sample, and if proteins like albumin are present, the strip changes color. It’s simple, non-invasive, and helpful for spotting early kidney damage.
If a dipstick shows abnormalities, the next step is often a UPCR test. This test measures exactly how much protein is leaking into the urine relative to creatinine. Higher levels may signal worsening kidney function or underlying disease. Doctors use UPCR to assess the severity of kidney damage and monitor progress over time.
If any test shows rising creatinine, an abnormal eGFR, protein in urine, or blood detected on a dipstick, it’s crucial to book an appointment. Lifestyle tweaks, home remedies, or detox drinks cannot reverse kidney damage. Expert evaluation is essential.
Credits: Canva
In 2025, thanks to climate change, rapid urbanization, and frequent travels, new viruses, their strains, and infections have spread frequently. Infections have affect millions and some diseases have come back with their new strains, which have been more contagious, whereas other diseases are finding new ways to emerge.
As we look back at the year, which is about to end in just another month, let us look back at the top 5 infectious diseases of 2025.
In 2025, respiratory infections were the most widespread, with new COVID-19 variants emerging every now and then. Along with this common flu too has emerged. This has weakened immunity and made elderly and infants, and people with comorbidities more vulnerable to the diseases.
The new COVID variants in India are linked with the JN.1 variant and its sub-variants like LF.7 and NB.1.8. The COVID variants in the UK which were active were XFG, NB.1.8.1, or known as the Stratus and Nimbus variants. Other variants were XFG.3, XFG.5, and XFG.3.4.1.
Tuberculosis still continues to be a major infectious disease in 2025, especially in countries like India. As per the World Health Organization (WHO), tuberculosis caused 1.25 billion deaths in 2023. It becomes the world's leading infectious disease after COVID-19.
Each day, close to 3,425 people lose their lives to TB, and close to 30,000 people fall ill with this preventable and curable disease. About 10.8 million people got TB in 2023, which include 6 million, 3.6 million women, and 1.3 million children.
Mosquito-borne diseases like dengue, chikungunya, malaria, and Zika continued to rise in 2025. The reason being changing weather patterns. Dr Sanjeev Bagai, Chairman of Nephron Clinic, and Senior Consultant Pediatrician and Nephrologist points out that earlier the mosquito-borne diseases were seasonal, however, due to rapid urbanization and climate changes, these diseases have stayed all round the year.
Hepatitis B and Hepatitis C are among the most common Hepatitis infections in 2025. However, there have been outbreaks of Hepatitis A and E in unsafe water and food. Chronic hepatitis can also damage liver and also lead to cancer. It is a concern because it spreads through contaminated food, unsafe water, blood, and sexual contact. While many people may not show symptoms until serious liver damage occurs.
Symptoms also include jaundice, dark urine, fatigue, nausea, and abdominal pain.
Food- and water-borne infections are still common across the world. Illnesses like salmonella, cholera, rotavirus, and norovirus often spread in areas where hygiene, sanitation, and food safety are poorly maintained.
They can spread extremely fast, especially among children and older adults. Severe diarrhea and vomiting can lead to dangerous dehydration if not treated in time.
Persistent diarrhea, vomiting, stomach cramps, fever, and signs of dehydration. The best prevention is simple: drink clean water, wash hands regularly, and eat properly cooked food.
(Credit-Canva)
When we think about cancer risk, it’s natural to wonder, “is it genetic?”
The truth is, sometimes it is, but in many cases, cancer develops from a mix of lifestyle, environmental factors, and DNA changes that occur over a lifetime. Understanding the difference between inherited genetic risks and those acquired along the way can help people make smarter decisions about screening, prevention, and treatment, and empower families to take proactive steps for their health.
Cancer arises from a series of changes/mutations in cells that disrupt normal growth control. Many of these changes happen over a person’s lifetime, influenced by exposures (like tobacco, UV rays, infections), aging, and random DNA errors. These are called “somatic mutations” and occur in our tissues—they are not inherited, and are not passed to children.
By contrast, a smaller fraction of cancers are influenced by inherited mutations called “germline mutations”; these are changes in the DNA that you are born with, and are present in every cell of your body. These mutations can predispose someone to cancer by impairing DNA repair, controlling cell division, or through other mechanisms. Approximately 5–10% of all cancers are thought to have a strong hereditary component.
So, while your DNA can influence your cancer risk, most cancers don’t occur because of an inherited gene defect. And even when a germline mutation is present, environment, lifestyle, and chance usually play significant roles in whether cancer actually develops.
When should we suspect hereditary cancers? Here are red flags:
A strong family history of cancer, especially the same type (e.g. multiple members with breast cancer, or several relatives with colon cancer).
Rare cancers or specific tumor types tied to known syndromes (e.g. medullary thyroid cancer, male breast cancer, pancreatic cancer in some families).
Known syndrome features, such as colon polyps and colon cancer in Lynch syndrome.
In such cases, genetic testing can identify mutations in genes like BRCA1/2, Lynch syndrome genes (MLH1, MSH2, MSH6, PMS2, EPCAM), TP53, PALB2, and others. Identifying carriers has implications for targeted screening (e.g. colonoscopic surveillance or mammography at regular intervals), preventive surgery like mastectomy, and sometimes therapy in case cancer does develop.
Imagine your cells are factories, following a strict set of instructions (your DNA). Inherited mutations can mean that a “safety check” is broken from the start. For example:
A mutation in the BRCA1 or BRCA2 genes weakens the cell’s ability to repair DNA. Over time, unrepaired damage accumulates, raising the risk of developing breast, ovarian, prostate, and pancreatic cancer.
Mutations in DNA mismatch repair genes (as in Lynch syndrome) allow errors during DNA copying to persist, boosting mutation load and increasing the risk of developing colon, endometrium, stomach, and other cancers.
But even when a high-risk mutation is present, cancer doesn’t appear overnight. Additional “hits”, or more mutations, microenvironment changes, hormonal exposures, or lifestyle factors need to typically accumulate before cells turn cancerous.
You might ask: if it’s a small percentage of cancers, does knowing about hereditary risk make a difference?
The answer is, yes, absolutely. Knowing your hereditary risk of cancer has some important benefits:
Prevention & early detection: If you carry a pathogenic mutation, you can undergo more frequent surveillance, chemoprevention (e.g. tamoxifen for breast cancer), or risk-reducing surgeries (e.g. prophylactic mastectomy or oophorectomy).
Therapeutic choices: Certain inherited mutations also influence how cancers respond to therapy. For example, PARP inhibitors are effective in tumors with BRCA-related homologous recombination deficiency (HRD). Thus, knowing that a patient has a germline BRCA mutation may alter drug selection.
Family risk & cascade testing: Identifying a hereditary mutation allows cascade testing, where close relatives can also get genetic testing done. This helps them understand risks and take prevention measures before cancer develops.
Clinical trial access: Many modern trials require knowledge of inherited DNA defects. Patients with known germline mutations may qualify for therapies designed precisely for those DNA repair vulnerabilities.
However, it is also important to understand that absence of a germline mutation does not mean absence of risk. Many cancers are driven purely by somatic mutations, and many hereditary variants remain undiscovered or classified as Variants of Uncertain Significance (VUS). Testing negative for known genes does not guarantee immunity.
Also, hereditary risk is not absolute: a person may carry a mutation but never develop cancer, due to protective factors like healthy lifestyle, background genetics, or luck. Interpretation must be done thoughtfully, ideally with genetic counselling.
While hereditary mutations play a role in a minority of cases, their impact on prevention, therapy, and family planning can be profound. Knowing whether cancer “came from your DNA” is often less important than using that knowledge wisely—both for patients and their relatives.
As we move deeper into the era of precision medicine, clinicians and patients alike should appreciate that hereditary and somatic worlds coexist, and that DNA insight is a tool—not a verdict.
© 2024 Bennett, Coleman & Company Limited